Venetoclax plus '2+5' modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single-centre retrospective analysis

被引：3
|
作者：
Wang, Huafeng [1 ,2 ,3 ,4 ]
Yao, Yiyi [1 ,2 ]
Mao, Liping [1 ,2 ]
Lou, Yinjun [1 ,2 ]
Ren, Yanling [1 ,2 ]
Ye, Xingnong [1 ,2 ]
Yang, Min [1 ,2 ]
Ma, Liya [1 ,2 ]
Zhang, Yi [1 ,2 ]
Zhou, Yile [1 ,2 ]
Wu, Jiaying [5 ]
Huang, Xin [1 ,2 ,3 ,4 ]
Wang, Yungui [1 ,2 ,3 ,4 ]
Xu, Huan [1 ,2 ]
Tong, Hongyan [1 ,2 ,3 ,4 ]
Zhu, Hong-Hu [1 ,2 ,3 ,4 ,6 ]
Jin, Jie [1 ,2 ,3 ,4 ,6 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Sch Med, Zhejiang, Peoples R China
[2] Zhejiang Univ, Zhejiang Prov Key Lab Hematopoiet Malignancy, Hangzhou, Peoples R China
[3] Zhejiang Univ Canc Ctr, Hangzhou, Peoples R China
[4] Zhejiang Prov Clin Res Ctr Hematol Disorders, Hangzhou, Peoples R China
[5] Zhejiang Univ, Affiliated Hosp 1, Dept Clin Pharm, Sch Med, Hangzhou, Peoples R China
[6] Zhejiang Univ Sch Med, Affiliated Hosp 1, Dept Hematol, 79 Qingchun Rd, Hangzhou 310003, Peoples R China
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷 / 03期
关键词：
acute myeloid leukaemia; DAV; efficacy; safety; venetoclax;
D O I：
10.1111/bjh.18709
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：568 / 572
页数：5
相关论文
共 7 条
  • [1] Outcomes of venetoclax combined with homoharringtonine and cytarabine in fit adults patients with de novo adverse-risk acute myeloid leukaemia: A single-centre retrospective analysis
    Song, Bao-Quan
    Kong, Xin
    Pu, Yan
    Liu, Yin
    Zhang, Jian
    Wu, De-Pei
    Qiu, Hui-Ying
    EJHAEM, 2023, 4 (04): : 1208 - 1211
  • [2] Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy
    Yamauchi, Takahiro
    Yoshida, Chikashi
    Usuki, Kensuke
    Takada, Satoru
    Matsumura, Itaru
    Dobashi, Nobuaki
    Miyazaki, Yasushi
    Miyamoto, Toshihiro
    Iida, Hiroatsu
    Asou, Norio
    Kuroda, Junya
    Ichikawa, Satoshi
    Komatsu, Norio
    Mendes, Wellington
    Honda, Hideyuki
    Okubo, Sumiko
    Kurokawa, Misaki
    Jiang, Qi
    Wei, Andrew
    Ishizawa, Kenichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (09) : 1372 - 1382
  • [3] Baseline chest computed tomography for diagnosis of invasive aspergillosis in patients with acute myeloid leukaemia treated with intensive chemotherapy: A retrospective single-centre cohort study
    Janssens, Emilie
    Huygens, Sammy
    Moors, Ine
    Delie, Anke
    Kerre, Tessa
    Vande Weygaerde, Yannick
    Van Braeckel, Eva
    Boelens, Jerina
    Morbee, Lieve
    Schauwvlieghe, Alexander
    MYCOSES, 2024, 67 (03)
  • [4] Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
    Laloi, Louise
    Billotey, Natacha Chaumard
    Dumas, Pierre-Yves
    Paul, Franciane
    Villate, Alban
    Simand, Celestine
    Fornecker, Luc
    Puisset, Florent
    Bertoli, Sarah
    Simonet, Marion Boissard
    Laribi, Kamel
    Houyou, Dyhia
    Santagostino, Alberto
    Michel, Claire
    Guepin, Gabrielle Roth
    Guerineau, Elodie
    Tabrizi, Reza
    Hunault, Mathilde
    Giltat, Aurelien
    Kaphan, Eleonore
    Bulabois, Claude
    Cartet, Elodie
    Rocher, Clement
    Lachenal, Florence
    Morisset, Stephane
    Recher, Christian
    Pigneux, Arnaud
    Belhabri, Amine
    Michallet, Mauricette
    Michallet, Anne-Sophie
    CANCER MEDICINE, 2023, 12 (06): : 7175 - 7181
  • [5] Venetoclax combined with hypomethylating agents or low-dose cytarabine as induction chemotherapy for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review and meta-analysis
    Yao Qin
    Pu Kuang
    Ting Liu
    Clinical and Experimental Medicine, 2023, 23 : 219 - 227
  • [6] Venetoclax combined with hypomethylating agents or low-dose cytarabine as induction chemotherapy for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review and meta-analysis
    Qin, Yao
    Kuang, Pu
    Liu, Ting
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (02) : 219 - 227
  • [7] Real-life experience of venetoclax and hypomethylating agents in acute myeloid leukemia patients not candidates for intensive chemotherapy or who are refractory/relapsed: A single-centre experience
    Roldan Perez, Alicia
    Vazquez Paganini, Juan Andres
    Penalva Moreno, M. Jose
    Gimenez Mesa, Eugenio
    Vilches Moreno, Alba Sara
    Nunez-Torron Stock, Claudia
    Herraez Garcia, Regina
    CLINICAL CASE REPORTS, 2022, 10 (07):
1